logo

Abbvie (ABBV)



Trade ABBV now with
  Date
  Headline
12/2/2020 8:02:09 AM Frontier Medicines, AbbVie Partner To Develop Novel Therapies And E3 Degraders Against Difficult-to-Drug Targets
11/10/2020 8:03:16 AM AbbVie Says Health Canada Approves MAVIRET
10/30/2020 8:19:25 AM AbbVie (ABBV) Declares Quarterly Dividend of $ 1.30, Record Date 1/15/2021
10/30/2020 8:17:51 AM AbbVie (ABBV) Has Raised Its FY20 EPS Estimate To 10.47 - 10.49 From 10.35 - 10.45
10/30/2020 7:48:46 AM AbbVie Q3 GAAP EPS $1.29; Adj EPS $2.83
10/29/2020 3:25:52 AM AbbVie To Present New Analyses From Pivotal Phase 3 Studies For RINVOQ In Atopic Dermatitis
10/28/2020 8:09:55 AM Allergan Announces Positive Phase 3 Topline Results For AGN-190584 For The Treatment Of Presbyopia
10/19/2020 10:08:30 AM AbbVie Says Submits Regulatory Applications To FDA And EMA For RINVOQ In Atopic Dermatitis
10/19/2020 8:59:23 AM AbbVie Reports Commencement Of Registered Exchange Offers
10/7/2020 8:03:48 AM Allergan Aesthetics To Buy Luminera's Full Dermal Filler Portfolio And R&D Pipeline
10/2/2020 8:32:01 AM AbbVie To Present New Data From 15 Abstracts At 2020 Virtual Migraine Trust International Symposium